Common cholesterol drug tested for rare childhood skin condition

NCT ID NCT05488067

Summary

This study tested whether the cholesterol-lowering drug atorvastatin is safe and effective for treating skin growths called xanthomas in children with Alagille Syndrome. It involved 15 children and teenagers, who took the drug for up to 6 months while doctors monitored changes in their skin growths and cholesterol levels. The goal was to see if this widely available pill could offer a simpler, less invasive treatment option for these often-disfiguring growths.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALAGILLE SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Children's Hospital of Fudan University

    Shanghai, Shanghai Municipality, 201102, China

Conditions

Explore the condition pages connected to this study.